| Mr John Christopher Barlow, MD | |
|
1011 W Baltimore Pike, Suite 301, West Grove, PA 19390-9446 | |
| (610) 869-3620 | |
| (610) 869-0358 |
| Full Name | Mr John Christopher Barlow |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1011 W Baltimore Pike, West Grove, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336102961 | NPI | - | NPPES |
| 1056539 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD036508E (Pennsylvania) | Primary |
| Entity Name | Tri-county Hospitalists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730518564 PECOS PAC ID: 4385872290 Enrollment ID: O20140122000447 |
News Archive
A Michigan State University surgeon is teaming up with a Lansing-area dental benefits firm on a clinical trial to create a simple, cost-effective saliva test to detect oral cancer, a breakthrough that would drastically improve screening and result in fewer people dying of the world's sixth most common cancer.
Ambry Genetics today announces that it is the first laboratory to provide CLIA-approved exome services for applications in clinical diagnostics. After comprehensive review by Ambry's staff of geneticists and medical directors, these results will allow clinicians to diagnose affected patients with conditions that have eluded traditional diagnostic approaches.
IMGM Laboratories GmbH has purchased a Fluidigm Access Array System to use in its development and validation of targeted re-sequencing applications services.
Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.
AGT Biosciences Limited of Melbourne, Australia and privately held ChemGenex Therapeutics, Inc. of Menlo Park, California, today announced that they have signed a merger agreement. The cross-border merger creates a new, genomics-driven pharmaceutical company with leading edge capabilities for drug discovery and development, as well as two drug candidates in Phase II human trials for cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr John Christopher Barlow, MD 1011 W Baltimore Pike, Suite 301, West Grove, PA 19390-9446 Ph: (610) 869-3620 | Mr John Christopher Barlow, MD 1011 W Baltimore Pike, Suite 301, West Grove, PA 19390-9446 Ph: (610) 869-3620 |
News Archive
A Michigan State University surgeon is teaming up with a Lansing-area dental benefits firm on a clinical trial to create a simple, cost-effective saliva test to detect oral cancer, a breakthrough that would drastically improve screening and result in fewer people dying of the world's sixth most common cancer.
Ambry Genetics today announces that it is the first laboratory to provide CLIA-approved exome services for applications in clinical diagnostics. After comprehensive review by Ambry's staff of geneticists and medical directors, these results will allow clinicians to diagnose affected patients with conditions that have eluded traditional diagnostic approaches.
IMGM Laboratories GmbH has purchased a Fluidigm Access Array System to use in its development and validation of targeted re-sequencing applications services.
Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.
AGT Biosciences Limited of Melbourne, Australia and privately held ChemGenex Therapeutics, Inc. of Menlo Park, California, today announced that they have signed a merger agreement. The cross-border merger creates a new, genomics-driven pharmaceutical company with leading edge capabilities for drug discovery and development, as well as two drug candidates in Phase II human trials for cancer.
› Verified 4 days ago
Mark S. Noveck, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1015 W Baltimore Pike, West Grove, PA 19390 Phone: 610-869-1068 Fax: 610-869-1023 | |
Dr. David M Callahan, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1011 W Baltimore Pike, Suite 301, West Grove, PA 19390 Phone: 610-869-3620 Fax: 610-869-0358 | |
Marie-claudia Durkin, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1015 W Baltimore Pike, West Grove, PA 19390 Phone: 484-429-2351 | |
Dr. John Aaron, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 900 West Baltimore Pike, Ste 101, West Grove, PA 19390 Phone: 610-869-9330 Fax: 610-869-0660 | |
Victor Galati, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 348 Mcneil Ln, West Grove, PA 19390 Phone: 610-345-0556 | |
Richard Ivan Plotzker, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1011 W Baltimore Pike, Suite 210, West Grove, PA 19390 Phone: 610-869-2224 Fax: 610-869-1481 |